SCHEMBL6167809

SCHEMBL6167809

CC(=O)Nc1ccc(C(=O)NCc2ccccn2)cc1N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.60
KDM4E B2RXH2 2/20 0.58
RAB9A P51151 5/20 0.55
NPC1 O15118 3/20 0.55
LMNA P02545 2/20 0.55
POLB P06746 1/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
CA2 P00918 1/20 0.54
HPGD P15428 2/20 0.52
MAPK14 Q16539 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NAMPT P43490 2/20 0.52
ALDH1A1 P00352 2/20 0.51
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
TSHR P16473 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172189 0.82 ALDH1A1 (0.63) BRD4KDM4ERAB9ANPC1LMNA
SCHEMBL10324601 0.81 KDM4E (0.70) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL20217165 0.79 KDM4E (0.58) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL13175833 0.78 KMT2A (0.66) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL11625676 0.77 LMNA (0.74) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL13947279 0.76 KDM4E (0.79) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL31396771 0.76 CYP1A2 (0.65) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL6170052 0.75 BRD4 (0.53) BRD4KDM4ERAB9ANPC1LMNA
SCHEMBL13102332 0.74 RAB9A (0.74) KDM4ERAB9ANPC1LMNAPOLB
SCHEMBL30287914 0.74 RAB9A (0.74) KDM4ERAB9ANPC1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed